Replacement of the Native Mitral Valve Using the ReValve System

Clinical trial NCT07601269 · RECRUITING

Trial details

NCT number: NCT07601269
Sponsor: ReValve Solutions Inc.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Mitral Valve Replacement

Start date: 2026-04-26
Primary completion: 2028-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.